
InVivoMAb anti-West Nile/dengue virus E protein

BE0325
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-West Nile/dengue virus E protein
- Delivery Days Customer7
- ApplicationsNeutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDE60
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostMouse
- IsotypeIgG2a
- ReactivityVirus
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- The Zika virus envelope protein glycan loop regulates virion antigenicity. Goo L et al., 2018 Feb, VirologyRead more
- A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus. Dowd KA et al., 2011 Jun, PLoS PathogRead more
- Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein. Oliphant T et al., 2006 Dec, J VirolRead more
- Structural basis of West Nile virus neutralization by a therapeutic antibody. Nybakken GE et al., 2005 Sep 29, NatureRead more